Mark B. Roth

Founder at Faraday Pharmaceuticals, Inc.

Retail Trade

Health Technology

Profile

Mark B.
Roth is the founder of Faraday Pharmaceuticals, Inc. established in 2014, where he currently holds the position of President and Director.
He is also currently a Director at Faraday Pharmaceuticals, Inc. (Washington).

Mark B. Roth active positions

Companies	Position	Start
Faraday Pharmaceuticals, Inc. Faraday Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Faraday Pharmaceuticals, Inc. engages in the research and development of elemental reducing agents (ERAs). Its therapeutic agents have potential applications for treatment of critical care illnesses. The company was founded by Mark B. Roth and Christopher Toombs in 2014 and is headquartered in Seattle, WA.	Founder	31/12/2013
Faraday Pharmaceuticals, Inc. (Washington) Faraday Pharmaceuticals, Inc. (Washington) Drugstore ChainsRetail Trade Faraday Pharmaceuticals, Inc. develops small molecule drugs for the treatment of central nervous system disorders and cardiovascular diseases. The company was founded in 2001 and is headquartered in Seattle, WA.	Director/Board Member	-

All active positions of Mark B. Roth

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Mark B. Roth's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Faraday Pharmaceuticals, Inc. (Washington) Faraday Pharmaceuticals, Inc. (Washington) Drugstore ChainsRetail Trade Faraday Pharmaceuticals, Inc. develops small molecule drugs for the treatment of central nervous system disorders and cardiovascular diseases. The company was founded in 2001 and is headquartered in Seattle, WA.	Retail Trade
Faraday Pharmaceuticals, Inc. Faraday Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Faraday Pharmaceuticals, Inc. engages in the research and development of elemental reducing agents (ERAs). Its therapeutic agents have potential applications for treatment of critical care illnesses. The company was founded by Mark B. Roth and Christopher Toombs in 2014 and is headquartered in Seattle, WA.	Health Technology